Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 107.50
Bid: 106.50
Ask: 107.00
Change: 1.50 (1.42%)
Spread: 0.50 (0.469%)
Open: 106.00
High: 108.50
Low: 106.00
Prev. Close: 106.00
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

18 Feb 2022 07:00

RNS Number : 0610C
McBride PLC
18 February 2022
 

18 February 2022

 

McBride plc

 

Board Changes

 

McBride plc ("McBride" or the "Company") announces the appointment of Regi Aalstad as a Non-Executive Director with effect from 14 March 2022.

 

Regi has extensive leadership experience in global fast moving consumer goods. She has held Regional General Manager and Vice President positions with Procter & Gamble in Europe, Asia, Middle East and Africa. Regi is a Non-Executive Director at Ontex Group NV and in several tech start-ups. She also works as an advisor to Private Equity and to global strategy consultancies. Regi holds a Master of Business Administration from the University of Michigan, USA.

 

She previously held Non-Executive Director positions at Telenor ASA, and Geberit AG and was the Chair of an international NGO.

 

Regi will serve as a member of the Nomination, Remuneration and Audit & Risk Committees. Regi's appointment satisfies the requirements of Provision 24 of the UK Corporate Governance Code.

 

Steve Hannam, Senior Independent Non-executive Director, having served nine years, will be stepping down from the Board immediately following the annual general meeting on 18th October 2022. Succession planning for his role as Senior Independent Director is underway and at the end of this process we should be in a position to release further information regarding the appointment of a new Senior Independent Director.

 

Jeff Nodland, Chairman of McBride commented:

 

"Regi brings extensive experience from the global fast moving consumer goods market. Her knowledge of the Asian and European markets, along with her strong board experience will be extremely beneficial to the Board. We are delighted to welcome Regi to McBride.

 

I would like to take the opportunity to thank Steve for his wise counsel and guidance over the last nine years. Steve's insight and contribution to Board discussions have been invaluable to the Board and the business, from which we will continue to benefit until the AGM. I wish him the very best for the future."

 

McBride has been notified that there are no further details to be disclosed in respect of Regi Aalstad pursuant to Rule 9.6.13 of the Listing Rules of the UK Listing Authority and this announcement is made in accordance with Listing Rule 9.6.11.

 

 

 

McBride plc

 

Jeff Nodland, Chairman

0161 203 7570

Chris Smith, CEO

 

 

 

FTI Consulting

 

Ed Bridges, Nick Hasell

020 3727 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFITFVIDLIF
Date   Source Headline
2nd May 20249:21 amRNSHolding(s) in Company
30th Apr 20247:00 amRNSTrading Update
8th Apr 202411:24 amRNSHolding(s) in Company
8th Apr 202411:22 amRNSHolding(s) in Company
5th Apr 20249:53 amRNSHolding(s) in Company
28th Mar 20243:20 pmRNSDirector/PDMR Shareholding
25th Mar 20241:52 pmRNSDirector/PDMR Shareholding
13th Mar 20247:00 amRNSCapital Markets Day
28th Feb 20242:30 pmRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSHalf-year Report
16th Jan 20247:00 amRNSTrading Update
13th Dec 20231:47 pmRNSDirector/PDMR Shareholding
20th Nov 20235:55 pmRNSDirector/PDMR Shareholding
20th Nov 20235:39 pmRNSResult of AGM
20th Nov 20237:00 amRNSAGM Trading Update
25th Oct 202310:22 amRNSTermination of ‘upside sharing’ mechanism
19th Oct 20237:00 amRNSTrading Update
17th Oct 20235:42 pmRNSPosting of ARA and Notice of AGM
4th Oct 20235:24 pmRNSVesting of RSU Awards
29th Sep 20237:00 amRNSDirector/PDMR Shareholding
22nd Sep 20235:33 pmRNSDirector/PDMR Shareholding
21st Sep 202310:54 amRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFinal Results
14th Jul 20237:00 amRNSFull year trading update
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20235:31 pmRNSDirectorate Change
25th May 20239:38 amRNSDirector Declaration
2nd May 20237:00 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNSTrading Update
11th Apr 20232:08 pmRNSDirector/PDMR Shareholding
3rd Apr 20232:39 pmRNSDirector/PDMR Shareholding
31st Mar 202312:27 pmRNSDirector/PDMR Shareholding
21st Mar 20235:59 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSHalf-year Report
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
1st Feb 20238:46 amRNSDirector Declaration
17th Jan 20237:00 amRNSTrading Update
11th Jan 20239:01 amRNSDirector Declaration
22nd Dec 20224:23 pmRNSDirector/PDMR Shareholding
13th Dec 20222:51 pmRNSDirector/PDMR Shareholding
16th Nov 20224:42 pmRNSAGM Statement
16th Nov 20227:00 amRNSAGM Trading Update
17th Oct 20227:00 amRNSAnnual Report 2022 and Annual General Meeting 2022
5th Oct 20225:55 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:07 pmRNSRedemption of B Shares
29th Sep 202212:49 pmRNSFinal Results
29th Sep 202211:51 amRNSAmended Financing Agreement
29th Sep 20227:00 amRNSPreliminary results timing
6th Sep 20222:51 pmRNSBoard Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.